"King Faisal Specialist Hospital" Holds The Immunotherapy of Tumors Conference this Saturday




King Faisal Specialist Hospital and Research Centre, in cooperation with the Saudi Oncology Society, is organizing the second annual conference on the immunotherapy of tumors on Saturday, 5th of March 2016 at the Marriott Hotel, Makarim Hall, in Riyadh.  

Dr. Shawki Bazerbashi, Consultant Oncologist at King Faisal Specialist Hospital and Research Centre in Riyadh and Chairman of the Organizing Committee explained that the conference will have 4 participants who are experts in Immunotherapy of tumors from the USA and Italy. This is in addition to a number of regional and local speakers. The conference will discuss, through four scientific sessions, the latest developments in Immunotherapy of tumors and the role of immunotherapy in the fight against various types of cancers such as lung, kidney, bladder, skin, lymph nodes and breast. This is in an effort, he added, to identify areas that need further scientific research and types of tumors where immunotherapy should be used as a standard treatment.

 “The immunotherapy of tumors is carried out in the use of the immune system to treat cancer where the human body normally fights the disease  by killing  cancer  cells before they develop into cancer”, he explained. He also pointed out that cancer has many ways to inhibit the immune system and avoiding the destruction of cancer cells. He emphasized the recent scientists’ discovery of a method to support immunity in its fight against cancer by using specific medications aiming at the immune cells and making them more effective against cancer cells.     

Dr. Mohammed Maimoon, consultant oncologist at King Faisal Specialist Hospital and Research Centre in Riyadh and Chairman of the Scientific Committee of the Conference, explained that an immunotherapy test is being carried out on most types of cancer. The treatment has proven effective on cancers of the lung, kidney, skin, and recently on blood cancer. He pointed out that there were indications to an effectiveness of immunotherapy in some types of cancer such as breast, colon, lymph nodes, liver and others.

The Saudi Commission for Health Specialties has accredited 7 training hours for attending this conference.